|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2008-9-15
|
|
pubmed:abstractText |
Recently, elevated liver enzymes have attracted great interest as potential novel markers of cardiovascular risk. Their association with angiographically determined coronary artery disease (CAD) is unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0009-8981
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
397
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
82-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18708042-Aged,
pubmed-meshheading:18708042-Alanine Transaminase,
pubmed-meshheading:18708042-Aspartate Aminotransferases,
pubmed-meshheading:18708042-Biological Markers,
pubmed-meshheading:18708042-Coronary Angiography,
pubmed-meshheading:18708042-Coronary Artery Disease,
pubmed-meshheading:18708042-Female,
pubmed-meshheading:18708042-Humans,
pubmed-meshheading:18708042-Liver,
pubmed-meshheading:18708042-Male,
pubmed-meshheading:18708042-Metabolic Syndrome X,
pubmed-meshheading:18708042-Middle Aged,
pubmed-meshheading:18708042-gamma-Glutamyltransferase
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis.
|
|
pubmed:affiliation |
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
